✦ LIBER ✦

Pharmacokinetic and pharmacodynamic study of a novel chimeric natriuretic peptide, CD-NP, in the normal dog

✍ Scribed by Candace YW Lee; Guido Boerrigter; Gail J Harty; John C Burnett

Publisher: BioMed Central
Year: 2007
Tongue: English
Weight: 412 KB
Volume: 7
Category: Article
ISSN: 1471-2210
DOI: 10.1186/1471-2210-7-s1-p38

No coin nor oath required. For personal study only.

✦ Synopsis

Publish with Bio Med Central and every scientist can read your work free of charge "BioMed Central will be the most significant development for disseminating the results of biomedical researc h in our lifetime.

📜 SIMILAR VOLUMES

Cardiorenal actions of a novel chimeric

Cardiorenal actions of a novel chimeric natriuretic peptide, CD-NP, as compared to C-type natriuretic peptide, in the normal dog

✍ Candace YW Lee; Guido Boerrigter; Gail J Harty; John C Burnett 📂 Article 📅 2007 🏛 BioMed Central 🌐 English ⚖ 420 KB

The novel dual GC-A and GC-B designer na

The novel dual GC-A and GC-B designer natriuretic peptide, cenderitide (CD-NP), enhances the renal actions of furosemide in a model of severe heart failure

✍ Lisa C Costello-Boerrigter; Guido Boerrigter; Sarah Mangiafico; Alessandro Catal 📂 Article 📅 2011 🏛 BioMed Central 🌐 English ⚖ 94 KB

A comparative study of the pharmacokinet

A comparative study of the pharmacokinetics and pharmacodynamics of atenolol, hydrochlorothiazide and amiloride in normal young and elderly subjects and elderly hypertensive patients

✍ K. Sabanathan; C. M. Castleden; H. K. Adam; J. Ryan; T. J. Fitzsimons 📂 Article 📅 1987 🏛 Springer 🌐 English ⚖ 681 KB

Cenderitide (CD-NP), a novel peptide des

Cenderitide (CD-NP), a novel peptide designed to activate both guanylyl cyclase B and A, activates the second messenger cGMP, suppresses aldosterone, and preserves GFR without reducing blood pressure in a proof-of-concept study in patients with chronic heart failure

✍ Lisa C Costello-Boerrigter; John A Schirger; Wayne L Miller; Guido Boerrigter; H 📂 Article 📅 2011 🏛 BioMed Central 🌐 English ⚖ 135 KB

Costello-Boerrigter et al.: Cenderitide (CD-NP), a novel peptide designed to activate both guanylyl cyclase B and A, activates the second messenger cGMP, suppresses aldosterone, and preserves GFR without reducing blood pressure in a proof-of-concept study in patients with chronic heart failure.

A preliminary study of the pharmacodynam

A preliminary study of the pharmacodynamics and pharmacokinetics of a novel enkephalin analogue [Tyr-D.Arg-Gly-Phe(4NO2)·Pro·NH2(BW443C)] in healthy volunteers

✍ J. Posner; K. Dean; S. Jeal; S. G. Moody; A. W. Peck; G. Rutter; A. Telekes 📂 Article 📅 1988 🏛 Springer 🌐 English ⚖ 534 KB